Much of the discussion revolves around the extent of PRLR expression by the tumor parenchyma, including which breast cancer subtypes and which PRLR isoforms, and importantly, whether PRL fuels tumor aggression or fosters a more differentiated phenotype. Here, PRL is linked to breast cancer.